Team:KULeuven
From 2008.igem.org
(Difference between revisions)
m |
m |
||
Line 20: | Line 20: | ||
|The ''2008 iGEM team of the Katholieke Universiteit Leuven'' works on '''a bacterial drug delivery system''', for instance for the production of a peptide such as vasoactive intestinal peptide as a potential treatment for Crohn's disease. The bacterial drug delivery system will have ''several advantages over classical drugs''. These are (a) the bacterium will produce the exact amount of drug necessary for each individual by means of a feedback control mechanism, (b) the bacterium will die upon a long symptomless period and (c) a possible development towards drugs being taken up in the bloodstream. | |The ''2008 iGEM team of the Katholieke Universiteit Leuven'' works on '''a bacterial drug delivery system''', for instance for the production of a peptide such as vasoactive intestinal peptide as a potential treatment for Crohn's disease. The bacterial drug delivery system will have ''several advantages over classical drugs''. These are (a) the bacterium will produce the exact amount of drug necessary for each individual by means of a feedback control mechanism, (b) the bacterium will die upon a long symptomless period and (c) a possible development towards drugs being taken up in the bloodstream. | ||
|} | |} | ||
+ | |||
+ | '''Nr of visitors:''' | ||
+ | <html> | ||
+ | <left><a href="http://www.buy-ad-links.com/" ><img border="0" src="http://www.yourhitstats.com/Buy_Links-3717204.png" alt="Buy Links"></a></left></html> |
Revision as of 09:16, 6 August 2008
dock/undock dropdown
Under construction...
Team wiki of the [http://www.kuleuven.be K.U.Leuven] [http://www.kuleuven.be/bioscenter BioSCENTer] team. |
The 2008 iGEM team of the Katholieke Universiteit Leuven works on a bacterial drug delivery system, for instance for the production of a peptide such as vasoactive intestinal peptide as a potential treatment for Crohn's disease. The bacterial drug delivery system will have several advantages over classical drugs. These are (a) the bacterium will produce the exact amount of drug necessary for each individual by means of a feedback control mechanism, (b) the bacterium will die upon a long symptomless period and (c) a possible development towards drugs being taken up in the bloodstream. |